Analysis of SARS-CoV-2 Variant-Specific Serum Antibodies Post-Vaccination Utilizing Immortalized Human Hepatocyte-like Cells (HLC) to Assess Development of Protective Immunity

Daniel P Collins, Clifford J Steer
doi: https://doi.org/10.1101/2023.08.08.23293863

Article usage

Article usage: August 2023 to July 2025

AbstractFullPdf
Aug 20233882060
Sep 20237774
Oct 20232852
Nov 20231701
Dec 20231102
Jan 2024601
Feb 20241326
Mar 20242128
Apr 2024927
May 20241812
Jun 2024503
Jul 2024304
Aug 20241447
Sep 20241042
Oct 20241014
Nov 20241816
Dec 20241025
Jan 2025935
Feb 2025673
Mar 2025241510
Apr 20251415
May 20251955
Jun 202527811
Jul 2025032
Back to top
Posted August 13, 2023.
Download PDF
Data/Code
Email
Analysis of SARS-CoV-2 Variant-Specific Serum Antibodies Post-Vaccination Utilizing Immortalized Human Hepatocyte-like Cells (HLC) to Assess Development of Protective Immunity
Daniel P Collins, Clifford J Steer
medRxiv 2023.08.08.23293863; doi: https://doi.org/10.1101/2023.08.08.23293863
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area